Alvin H Schmaier Selected Research

splitomicin

1/2015

Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alvin H Schmaier Research Topics

Disease

29	Thrombosis (Thrombus) 11/2021 - 12/2002
12	Hemorrhage 12/2021 - 09/2007
5	Hypertension (High Blood Pressure) 10/2020 - 05/2003
4	Neoplasms (Cancer) 11/2021 - 09/2007
3	Hemophilia A (Haemophilia) 07/2020 - 09/2008
3	Sepsis (Septicemia) 01/2018 - 05/2002
2	COVID-19 10/2020 - 08/2020
2	Hereditary Angioedemas 01/2019 - 01/2018
2	Venous Thromboembolism 01/2019 - 09/2007
2	Edema (Dropsy) 01/2018 - 11/2012
2	Vascular Diseases (Vascular Disease) 01/2018 - 04/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016 - 05/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2014 - 01/2009
2	Carotid Artery Thrombosis 04/2013 - 11/2004
2	Infections 12/2010 - 01/2009
2	Prostatic Neoplasms (Prostate Cancer) 11/2010 - 11/2002
2	Neoplasm Metastasis (Metastasis) 11/2010 - 11/2002
2	Thrombocytopenia (Thrombopenia) 01/2009 - 09/2005
1	Aortic Dissection 12/2021
1	Disseminated Intravascular Coagulation 12/2021
1	Endoleak 12/2021
1	Disease Susceptibility (Diathesis) 07/2020
1	Thrombotic Thrombocytopenic Purpura 01/2020
1	Common Variable Immunodeficiency 01/2020
1	Fibrosis (Cirrhosis) 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Arthritis (Polyarthritis) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Polyps 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2016
1	Pyruvate Kinase Deficiency of Red Cells 01/2016
1	Prekallikrein Deficiency 01/2016

Drug/Important Bio-Agent (IBA)

9	PrekallikreinIBA 11/2021 - 05/2003
7	Thrombin FDA Link 12/2021 - 11/2002
7	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2002
7	Plasma KallikreinIBA 01/2018 - 12/2002
6	Factor XII (Hageman Factor)IBA 11/2021 - 02/2008
6	Thromboplastin (Tissue Factor)IBA 11/2021 - 04/2012
6	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2020 - 07/2006
5	KininsIBA 01/2016 - 12/2002
4	PolyphosphatesIBA 11/2021 - 11/2012
4	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2018 - 06/2003
4	Bradykinin B2 ReceptorIBA 05/2014 - 07/2006
3	Blood Coagulation Factors (Coagulation Factor)IBA 12/2021 - 09/2008
3	Sirtuin 1IBA 10/2020 - 01/2015
3	FibrinIBA 01/2020 - 11/2012
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2009
3	CollagenIBA 01/2018 - 07/2009
3	P-SelectinIBA 01/2018 - 12/2005
3	Peptides (Polypeptides)IBA 01/2018 - 04/2009
3	Heparin (Liquaemin)FDA LinkGeneric 02/2014 - 09/2005
2	Angiotensin IIIBA 10/2020 - 04/2013
2	AntibodiesIBA 07/2020 - 11/2011
2	Biological ProductsIBA 10/2019 - 01/2018
2	nimesulide (Aulin)IBA 01/2015 - 07/2006
2	7-Ala-angiotensin (1-7)IBA 01/2015 - 04/2013
2	CalciumIBA 05/2014 - 11/2002
2	lysosomal Pro-X carboxypeptidaseIBA 08/2013 - 04/2011
2	NitratesIBA 04/2013 - 07/2006
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2013 - 07/2006
2	Kininogens (Kininogen)IBA 02/2008 - 06/2003
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2007 - 09/2005
2	AngiotensinsIBA 07/2006 - 01/2004
2	ReninIBA 07/2006 - 01/2004
1	Dacarbazine (DIC)FDA LinkGeneric 12/2021
1	Angiotensin-Converting Enzyme 2IBA 10/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 10/2020
1	Angiotensin Receptor AntagonistsIBA 08/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2020
1	Factor VIII (Coagulation Factor VIII)IBA 07/2020
1	Everolimus FDA Link 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	SteroidsIBA 01/2020
1	carbopol 940 (sodium polyacrylate)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	NivolumabIBA 01/2019
1	ponatinibIBA 01/2019
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2019
1	Fibrinogen (Factor I)FDA Link 01/2018
1	BradykininIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Kallikreins (Kallikrein)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	Nylons (Nylon)IBA 01/2016
1	splitomicinIBA 01/2015
1	AVE 0991IBA 01/2015
1	ferric chlorideIBA 01/2015
1	Epoprostenol ReceptorsIBA 01/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2015

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2009
3	Transplantation 07/2014 - 01/2009
2	Plasma Exchange 01/2020 - 01/2009
2	Stem Cell Transplantation 07/2014 - 01/2009
1	Endovascular Aneurysm Repair 12/2021
1	Chemoprevention 01/2019
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2019